Becerril Morencos, Jesús Blázquez Gamero, Daniel Vergas Gutiérrez, Joaquín de Folgueira López, María Dolores Nuñez Ramos, Raquel Rojo Conejo, Pablo
Diagnóstico precoz de la infección congénita por citomegalovirus: oportunidades perdidas. [artículo] - Enfermedades Infecciosas y Microbiología Clínica, 2013 - 31(2):93-6.
Formato Vancouver:
Nuñez-Ramos R, Becerril J, Blázquez D, Rojo P, de Vergas J, Folgueira D, et al. Diagnóstico precoz de la infección congénita por citomegalovirus: oportunidades perdidas. Enferm Infecc Microbiol Clin. 2013 Feb;31(2):93-6.
PMID: 22902268
Contiene 10 referencias
Cytomegalovirus (CMV) infection is the most common congenital infection in Europe. Symptoms are present at birth in 10% of infected children, and up to 30-40% have some degree of hearing loss after the newborn period.
METHODS: A retrospective study was performed over a period of 4 years and included all patients with congenital CMV infection diagnosed after the neonatal period using the dried blood spots from neonatal metabolic screening.
RESULTS: We present 5 patients diagnosed with congenital CMV infection outside the neonatal period. The main reasons for consultation were hearing loss and/or neurological impairment in the first few months of life.
DISCUSSION: Congenital CMV infection may be mildly symptomatic at birth, and present as hearing loss and/or neurological impairment in infancy. Therefore, a high degree of suspicion is necessary in order to make an accurate diagnosis and start specific treatment to improve the outcome.
Diagnóstico precoz de la infección congénita por citomegalovirus: oportunidades perdidas. [artículo] - Enfermedades Infecciosas y Microbiología Clínica, 2013 - 31(2):93-6.
Formato Vancouver:
Nuñez-Ramos R, Becerril J, Blázquez D, Rojo P, de Vergas J, Folgueira D, et al. Diagnóstico precoz de la infección congénita por citomegalovirus: oportunidades perdidas. Enferm Infecc Microbiol Clin. 2013 Feb;31(2):93-6.
PMID: 22902268
Contiene 10 referencias
Cytomegalovirus (CMV) infection is the most common congenital infection in Europe. Symptoms are present at birth in 10% of infected children, and up to 30-40% have some degree of hearing loss after the newborn period.
METHODS: A retrospective study was performed over a period of 4 years and included all patients with congenital CMV infection diagnosed after the neonatal period using the dried blood spots from neonatal metabolic screening.
RESULTS: We present 5 patients diagnosed with congenital CMV infection outside the neonatal period. The main reasons for consultation were hearing loss and/or neurological impairment in the first few months of life.
DISCUSSION: Congenital CMV infection may be mildly symptomatic at birth, and present as hearing loss and/or neurological impairment in infancy. Therefore, a high degree of suspicion is necessary in order to make an accurate diagnosis and start specific treatment to improve the outcome.